nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Author’s reply to Veloso HH Comment on “The Role of Digitalis Pharmacokinetics in Converting Atrial Fibrillation and Flutter to Sinus Rhythm”
|
Jelliffe, Roger W. |
|
2016 |
55 |
5 |
p. 637-639 |
artikel |
2 |
Clinical Pharmacokinetics of Dulaglutide in Patients with Type 2 Diabetes: Analyses of Data from Clinical Trials
|
Geiser, Jeanne S. |
|
2015 |
55 |
5 |
p. 625-634 |
artikel |
3 |
Comment on: “The Role of Digitalis Pharmacokinetics in Converting Atrial Fibrillation and Flutter to Sinus Rhythm”
|
Veloso, Henrique Horta |
|
2016 |
55 |
5 |
p. 635-636 |
artikel |
4 |
Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics
|
Mooij, Miriam G. |
|
2015 |
55 |
5 |
p. 507-524 |
artikel |
5 |
Effects of Age, Sex, and Race on the Safety and Pharmacokinetics of Single and Multiple Doses of Azilsartan Medoxomil in Healthy Subjects
|
Harrell, Robert E. |
|
2015 |
55 |
5 |
p. 595-604 |
artikel |
6 |
Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator Riociguat in Healthy Young Chinese Male Non-Smokers and Smokers: Results of a Randomized, Double-Blind, Placebo-Controlled Study
|
Zhao, Xia |
|
2015 |
55 |
5 |
p. 615-624 |
artikel |
7 |
Pharmacokinetics, Pharmacodynamics and Pharmacogenomics of Immunosuppressants in Allogeneic Haematopoietic Cell Transplantation: Part I
|
McCune, Jeannine S. |
|
2015 |
55 |
5 |
p. 525-550 |
artikel |
8 |
Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II
|
McCune, Jeannine S. |
|
2015 |
55 |
5 |
p. 551-593 |
artikel |
9 |
Use of Multiple Probes to Assess Transporter- and Cytochrome P450-Mediated Drug–Drug Interaction Potential of the Pangenotypic HCV NS5A Inhibitor Velpatasvir
|
Mogalian, Erik |
|
2015 |
55 |
5 |
p. 605-613 |
artikel |